NEWS

Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Targeted Blockage! Sansure solution for detecting SARS-CoV-2 variant “Omicron”

On local time November 26, WHO held an emergency session and released a statement in which the SARS-CoV-2 variant B.1.1.529 was listed as a “Variant of Concern” and named after the Greek letter Omicron. According to WHO, the Omicron variant was first reported in South Africa. Preliminary studies showed that the variant has increased the risk of SARS-CoV-2 infection in […]

LEARN MORE
Sansure Biotech’s “Full Scenario Solution” Appeared at MEDICA 2021, With Global Partners Gathered at the Booth

From November 15-18, MEDICA was held in Düsseldorf, Germany. As the world’s largest medical industry event, MEDICA attracted thousands of companies from more than 60 countries and regions to exhibit their latest medical technologies and products. Sansure Biotech presented the full scenario solution for COVID-19, respiratory and reproductive tract infections at the exhibition. In Sansure’s booth, the “Fully Automated Solution” […]

LEARN MORE
With a capital contribution of 50 million, Sansure and KHB set up a joint venture to win together!

On November 8, Sansure and KHB signed the Letter of Intent for Investment Framework, to establish cooperation in chemiluminescence immunization subdivision to draw on each other’s strengths and achieve win-win results. According to the agreement, Sansure and KHB jointly invest 50 million yuan to establish a joint venture company “Sansure Immunotech” (proposed), with each side holding 50% of the equity. […]

LEARN MORE
An International Award! Sansure Biotech Inc. Won the G20 Medical Innovation Award

On October 10, Sansure Biotech Inc. won the Medical Innovation Award in the G20 Innovation Alliance Forum held in Sorrento, Italy, making it the only Chinese company receiving this honor. This first ever event in the history of G20 was hosted by the rotating presidency Italy this time, and it was dedicated to sharing ideas and innovative solutions in response […]

LEARN MORE
Global Strategic Cooperation Agreement Signed! Sansure Escorts the Overseas Business of PowerChina International

According to the agreement, Sansure will work closely with PowerChina International against the backdrop of the grim and complex COVID-19 outbreak overseas. The two parties will exchange experience, resources and reference cases, actively explore and enhance technical support for nucleic acid testing equipment, customer service and joint promotion. This cooperation will help ensure equipment availability and bio-safety, and strengthen protection […]

LEARN MORE
1 2 3 4